Ovid transfers global soticlestat rights to Perceptive Advisors–backed NewCo for equity, up to $294.5M milestones plus royalties
- Reported fiscal Q2 2026 non-GAAP EPS -$0.08 (-33% YoY), beating EPS estimates
- Fiscal Q2 2026 revenue $733,000 (-88% YoY), exceeding revenue estimates
- Filed Q2 10-Q reporting $15 million net loss and $169.8 million in cash
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.